The revenue stands at ₹529.12 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.60 per cent from ₹465.78 crore. This corresponds to a year-on-year *(YoY) growth of 43.02 per cent.
Operating Profit stands at ₹141.86 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.10 per cent from ₹136.27 crore. This corresponds to a year-on-year *(YoY) growth of 31.15 per cent.
PBDT stands at ₹137.82 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.42 per cent from ₹133.26 crore. This corresponds to a year-on-year *(YoY) growth of 46.21 per cent.
Profit Before Tax stands at ₹103.53 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.58 per cent from ₹98.06 crore. This corresponds to a year-on-year *(YoY) growth of 60.66 per cent.
Net Profit stands at ₹79.18 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.51 per cent from ₹100.88 crore. This represents a 79.67 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Shilpa Medicare | 4.96% | 3.57% | 2.65% | 20.14% | 118.91% | 160.12% |
| Neuland Labs. | 3.57% | 5.18% | 3.49% | -10.32% | 25.17% | 19.76% |
| Granules India | 5.37% | 4.28% | 4.07% | -2.01% | 14.37% | 53.73% |
| Alembic Pharma | 1.67% | 3.80% | 32.12% | 25.94% | 33.10% | 15.95% |
| OneSource Speci. | 2.35% | -0.62% | 12.30% | 4.53% | -10.89% | -6.53% |
| Caplin Point Lab | -4.95% | -2.50% | 2.20% | -3.72% | 18.06% | 24.12% |
| Cohance Life | 1.99% | 6.92% | 5.82% | 7.03% | 6.02% | -23.33% |
Chairman & Non Executive Dir. : Omprakash Inani
ED / MD / Promoter : Vishnukant Bhutada
Independent Non Exe. Director : Hetal Gandhi
E D & Wholetime Director : Sharath Reddy Kalakota
Independent Non Exe. Director : Anita Bandyopadhyay
Independent Non Exe. Director : Ashraf Loutfy Abdelhamid Allam
Company Sec. & Compli. Officer : Ritu Tiwary